Global Expansion Leverage SPRI’s growing footprint in the USA, Ukraine, Russia, Turkey, Mexico, and Georgia to target multinational sponsors seeking CRO partners capable of coordinating complex global trials with fast startup and strong enrollment.

Therapeutic Diversification Capitalize on SPRI’s expanding therapeutic areas in Cancer, Infectious Disease, Hepatitis, Psychiatry and Neurology to approach sponsors with multi-indication portfolios and cross-therapy trial management needs.

Quality and Reliability Highlight high enrollment performance and low staff turnover as indicators of reliable trial delivery, with 40% of work performed for other CROs, signaling strong quality partnerships and potential white-label or coverage opportunities.

Protocol Speed Position SPRI’s fast startup, rapid enrollment and robust site-network as a differentiator for sponsors facing tight timelines and complex global study requirements, especially in regions like Eastern and Central Europe.

Strategic Partnerships Target collaboration opportunities with larger CROs that rely on SPRI for regional coverage or trial execution in Europe and Australasia, leveraging SPRI’s network to expand joint capabilities and reduce time-to-site.